CGS
vs
S
S&P/ASX 300
CGS
Over the past 12 months, CGS has significantly outperformed S&P/ASX 300, delivering a return of +92% compared to the S&P/ASX 300's +6% growth.
Stocks Performance
CGS vs S&P/ASX 300
Performance Gap
CGS vs S&P/ASX 300
Performance By Year
CGS vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
CogState Ltd
Glance View
Cogstate Ltd. is a global cognitive science company. The firm provides computerized cognitive tests across various domains and support electronic clinical outcome assessment (eCOA) solutions. The firm's segment includes Clinical trials, Healthcare and Research. In the Clinical trials segment, the Company's technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians to assess cognitive decline. Research segment offers various research studies and academic collaborations across various indication of diseases.